Concepedia

Xuhong Min

XM

Statistics

Publications

8

Citations

1.9K

H-Index

8

Active since

2021

Affiliations

Xi'an Chest Hospital(Current)

Jilin Province Tumor Hospital

First Affiliated Hospital of Zhengzhou University

Third Affiliated Hospital of Harbin Medical University

Peking University

Xuhong Min is an author at Xi'an Chest Hospital specializing in oncology, medicine, and cancer pharmacology.

ORCID

Publications per year

2021–2024

8

Publications

8

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Jin Lü, Yuxian Bai, Teng Mao et al. · JAMA · 2021 · 801 citations · Full text

, , +17

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text

, , +17

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Jie Wang, Caicun Zhou, Wenxiu Yao et al. · The Lancet Oncology · 2022 · 395 citations

, , +11

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

Hongyun Zhao, Wenxiu Yao, Xuhong Min et al. · Journal of Thoracic Oncology · 2021 · 121 citations · Full text

, , +8

Reconstruction-Assisted Feature Encoding Network for Histologic Subtype Classification of Non-Small Cell Lung Cancer

Haichun Li, Qilong Song, Dongqi Gui et al. · IEEE Journal of Biomedical and Health Informatics · 2022 · 30 citations

, , +16

1–5 of 8